CN Stock MarketDetailed Quotes

603963 Dali Pharmaceutical

Watchlist
  • 2.94
  • +0.14+5.00%
Market Closed Jul 19 15:00 CST
645.92MMarket Cap-28269P/E (TTM)

Dali Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-58.47%15.32M
-34.06%87.27M
-27.06%73.27M
-14.51%59.57M
-7.36%36.89M
-22.83%132.34M
-22.21%100.46M
-24.30%69.68M
-18.74%39.82M
-19.71%171.49M
Operating revenue
-58.47%15.32M
-34.06%87.27M
-27.06%73.27M
-14.51%59.57M
-7.36%36.89M
-22.83%132.34M
-22.21%100.46M
-24.30%69.68M
-18.74%39.82M
-19.71%171.49M
Other operating revenue
----
4,463.09%860.47K
----
3,892.13%376.4K
----
-15.38%18.86K
----
0.00%9.43K
----
19.80%22.29K
Total operating cost
-45.71%21.99M
-27.32%113.27M
-22.14%90.85M
-11.88%71.2M
-8.34%40.51M
-15.85%155.84M
-16.27%116.68M
-16.89%80.79M
-12.97%44.2M
-14.05%185.19M
Operating cost
-16.94%13.53M
-11.79%50.97M
-13.01%37.96M
-5.71%29.19M
26.83%16.29M
25.78%57.79M
33.22%43.63M
36.16%30.95M
8.01%12.85M
-21.22%45.94M
Operating tax surcharges
-31.18%615.91K
2.82%3.21M
12.07%2.38M
42.92%1.74M
19.95%894.9K
-12.57%3.12M
-21.04%2.12M
-32.70%1.22M
-21.91%746.07K
-0.72%3.57M
Operating expense
-82.87%3.22M
-46.02%39.78M
-34.31%36.45M
-21.40%30.33M
-14.76%18.78M
-26.89%73.69M
-27.19%55.49M
-29.34%38.58M
-23.38%22.03M
-20.81%100.79M
Administration expense
-5.88%3.68M
-13.25%16.86M
-15.04%12.13M
-10.96%8.43M
-52.38%3.91M
-41.82%19.43M
-46.56%14.28M
-46.10%9.46M
-8.13%8.22M
41.09%33.4M
Financial expense
-48.66%246.08K
80.61%1.61M
250.24%1.27M
3,293.76%929.97K
5,764.75%479.31K
1,823.74%889.65K
847.33%362.71K
165.17%27.4K
117.10%8.17K
120.75%46.25K
-Interest expense (Financial expense)
-48.54%269.29K
58.50%1.71M
168.11%1.37M
681.20%1M
722.18%523.32K
335.85%1.08M
524.61%509.32K
135.54%128.04K
--63.65K
--247.35K
-Interest Income (Financial expense)
50.92%-25.7K
43.65%-117.68K
29.63%-107.99K
28.55%-79.91K
13.63%-52.37K
8.59%-208.85K
-1.20%-153.45K
0.59%-111.83K
-8.96%-60.63K
10.43%-228.47K
Research and development
360.18%699.46K
-9.44%839.52K
-16.38%662.56K
7.83%583.58K
-56.27%152K
-35.66%926.99K
-23.07%792.38K
0.77%541.2K
21.51%347.58K
-49.07%1.44M
Credit Impairment Loss
90.21%-13.07K
-153.14%-144.97K
-67.94%178.46K
21.83%62.39K
-1,272.94%-133.52K
359.65%272.84K
600.30%556.74K
-71.14%51.21K
-86.31%11.38K
-140.53%-105.08K
Asset Impairment Loss
----
1,681.21%3.6M
----
----
---2.74K
100.64%201.96K
----
----
----
-14,792,679.95%-31.62M
Other net revenue
-27.88%1.01M
41.47%8.96M
-21.40%4.38M
-11.42%3M
-13.52%1.4M
124.26%6.33M
6.91%5.57M
-14.92%3.39M
-21.88%1.62M
-446.05%-26.11M
Fair value change income
-36.02%854.42K
-10.12%4.68M
-20.88%3.58M
-12.93%2.5M
-14.63%1.34M
1,812.46%5.21M
200.60%4.53M
1,628.85%2.87M
-19.34%1.56M
-158.73%-303.98K
Invest income
4.87%115.8K
17.01%514.66K
37.59%424.73K
4.37%322.17K
--110.42K
-91.98%439.85K
-91.00%308.68K
-92.12%308.68K
----
-13.35%5.49M
Asset deal income
----
--52.46K
--52.46K
--52.46K
--52.46K
----
----
----
----
----
Other revenue
36.84%52.99K
22.93%262.5K
-20.75%138.72K
-60.32%60.72K
-12.34%38.72K
-50.49%213.54K
-54.42%175.04K
109.59%153.04K
-13.42%44.18K
1.25%431.33K
Operating profit
-154.59%-5.66M
0.76%-17.04M
-23.91%-13.2M
-11.72%-8.62M
19.48%-2.22M
56.87%-17.17M
-113.07%-10.65M
-556.16%-7.72M
-1,069.60%-2.76M
-804.16%-39.8M
Add:Non operating Income
283.06%35.35K
-90.10%26.61K
-38.12%23.91K
-33.78%18.54K
3.58%9.23K
420.76%268.83K
113.61%38.64K
207.84%28.01K
107.95%8.91K
7.94%51.62K
Less:Non operating expense
-99.83%179.48
258.82%359.57K
258.55%358.8K
258.55%358.8K
--106.73K
-94.55%100.21K
-90.64%100.07K
-8.08%100.07K
----
-4.48%1.84M
Total profit
-142.38%-5.63M
-2.18%-17.37M
-26.32%-13.53M
-15.06%-8.96M
15.67%-2.32M
59.13%-17M
-77.09%-10.71M
-510.51%-7.79M
-1,082.25%-2.75M
-1,201.50%-41.59M
Less:Income tax cost
-209.69%-252.29K
278.31%2.66M
143.13%1.85M
159.91%1.82M
-49.38%230K
135.68%703.97K
887.50%762.71K
778.15%699.44K
401.07%454.35K
-45.12%298.7K
Net profit
FPtoL-5.38M
FPtoL-20.03M
FPtoL-15.39M
FPtoL-10.78M
FPtoL-2.55M
FPtoL-17.7M
FPtoL-11.48M
FPtoL-8.49M
SL-3.21M
SL-41.89M
Net profit from continuing operation
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
-1,396.25%-41.89M
Net profit of parent company owners
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
-1,396.25%-41.89M
Earning per share
Basic earning per share
-111.21%-0.0245
-12.50%-0.09
-34.10%-0.07
-27.20%-0.0491
20.55%-0.0116
57.89%-0.08
-92.62%-0.0522
-628.30%-0.0386
-1,722.22%-0.0146
-2,000.00%-0.19
Diluted earning per share
-111.21%-0.0245
-12.50%-0.09
-34.10%-0.07
-27.20%-0.0491
20.55%-0.0116
57.89%-0.08
-92.62%-0.0522
-628.30%-0.0386
-1,722.22%-0.0146
-2,000.00%-0.19
Other composite income
Total composite income
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
-1,396.25%-41.89M
Total composite income of parent company owners
-110.65%-5.38M
-13.16%-20.03M
-34.08%-15.39M
-26.99%-10.78M
20.45%-2.55M
57.74%-17.7M
-92.78%-11.48M
-623.82%-8.49M
-1,791.60%-3.21M
-1,396.25%-41.89M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -58.47%15.32M-34.06%87.27M-27.06%73.27M-14.51%59.57M-7.36%36.89M-22.83%132.34M-22.21%100.46M-24.30%69.68M-18.74%39.82M-19.71%171.49M
Operating revenue -58.47%15.32M-34.06%87.27M-27.06%73.27M-14.51%59.57M-7.36%36.89M-22.83%132.34M-22.21%100.46M-24.30%69.68M-18.74%39.82M-19.71%171.49M
Other operating revenue ----4,463.09%860.47K----3,892.13%376.4K-----15.38%18.86K----0.00%9.43K----19.80%22.29K
Total operating cost -45.71%21.99M-27.32%113.27M-22.14%90.85M-11.88%71.2M-8.34%40.51M-15.85%155.84M-16.27%116.68M-16.89%80.79M-12.97%44.2M-14.05%185.19M
Operating cost -16.94%13.53M-11.79%50.97M-13.01%37.96M-5.71%29.19M26.83%16.29M25.78%57.79M33.22%43.63M36.16%30.95M8.01%12.85M-21.22%45.94M
Operating tax surcharges -31.18%615.91K2.82%3.21M12.07%2.38M42.92%1.74M19.95%894.9K-12.57%3.12M-21.04%2.12M-32.70%1.22M-21.91%746.07K-0.72%3.57M
Operating expense -82.87%3.22M-46.02%39.78M-34.31%36.45M-21.40%30.33M-14.76%18.78M-26.89%73.69M-27.19%55.49M-29.34%38.58M-23.38%22.03M-20.81%100.79M
Administration expense -5.88%3.68M-13.25%16.86M-15.04%12.13M-10.96%8.43M-52.38%3.91M-41.82%19.43M-46.56%14.28M-46.10%9.46M-8.13%8.22M41.09%33.4M
Financial expense -48.66%246.08K80.61%1.61M250.24%1.27M3,293.76%929.97K5,764.75%479.31K1,823.74%889.65K847.33%362.71K165.17%27.4K117.10%8.17K120.75%46.25K
-Interest expense (Financial expense) -48.54%269.29K58.50%1.71M168.11%1.37M681.20%1M722.18%523.32K335.85%1.08M524.61%509.32K135.54%128.04K--63.65K--247.35K
-Interest Income (Financial expense) 50.92%-25.7K43.65%-117.68K29.63%-107.99K28.55%-79.91K13.63%-52.37K8.59%-208.85K-1.20%-153.45K0.59%-111.83K-8.96%-60.63K10.43%-228.47K
Research and development 360.18%699.46K-9.44%839.52K-16.38%662.56K7.83%583.58K-56.27%152K-35.66%926.99K-23.07%792.38K0.77%541.2K21.51%347.58K-49.07%1.44M
Credit Impairment Loss 90.21%-13.07K-153.14%-144.97K-67.94%178.46K21.83%62.39K-1,272.94%-133.52K359.65%272.84K600.30%556.74K-71.14%51.21K-86.31%11.38K-140.53%-105.08K
Asset Impairment Loss ----1,681.21%3.6M-----------2.74K100.64%201.96K-------------14,792,679.95%-31.62M
Other net revenue -27.88%1.01M41.47%8.96M-21.40%4.38M-11.42%3M-13.52%1.4M124.26%6.33M6.91%5.57M-14.92%3.39M-21.88%1.62M-446.05%-26.11M
Fair value change income -36.02%854.42K-10.12%4.68M-20.88%3.58M-12.93%2.5M-14.63%1.34M1,812.46%5.21M200.60%4.53M1,628.85%2.87M-19.34%1.56M-158.73%-303.98K
Invest income 4.87%115.8K17.01%514.66K37.59%424.73K4.37%322.17K--110.42K-91.98%439.85K-91.00%308.68K-92.12%308.68K-----13.35%5.49M
Asset deal income ------52.46K--52.46K--52.46K--52.46K--------------------
Other revenue 36.84%52.99K22.93%262.5K-20.75%138.72K-60.32%60.72K-12.34%38.72K-50.49%213.54K-54.42%175.04K109.59%153.04K-13.42%44.18K1.25%431.33K
Operating profit -154.59%-5.66M0.76%-17.04M-23.91%-13.2M-11.72%-8.62M19.48%-2.22M56.87%-17.17M-113.07%-10.65M-556.16%-7.72M-1,069.60%-2.76M-804.16%-39.8M
Add:Non operating Income 283.06%35.35K-90.10%26.61K-38.12%23.91K-33.78%18.54K3.58%9.23K420.76%268.83K113.61%38.64K207.84%28.01K107.95%8.91K7.94%51.62K
Less:Non operating expense -99.83%179.48258.82%359.57K258.55%358.8K258.55%358.8K--106.73K-94.55%100.21K-90.64%100.07K-8.08%100.07K-----4.48%1.84M
Total profit -142.38%-5.63M-2.18%-17.37M-26.32%-13.53M-15.06%-8.96M15.67%-2.32M59.13%-17M-77.09%-10.71M-510.51%-7.79M-1,082.25%-2.75M-1,201.50%-41.59M
Less:Income tax cost -209.69%-252.29K278.31%2.66M143.13%1.85M159.91%1.82M-49.38%230K135.68%703.97K887.50%762.71K778.15%699.44K401.07%454.35K-45.12%298.7K
Net profit FPtoL-5.38MFPtoL-20.03MFPtoL-15.39MFPtoL-10.78MFPtoL-2.55MFPtoL-17.7MFPtoL-11.48MFPtoL-8.49MSL-3.21MSL-41.89M
Net profit from continuing operation -110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M-1,396.25%-41.89M
Net profit of parent company owners -110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M-1,396.25%-41.89M
Earning per share
Basic earning per share -111.21%-0.0245-12.50%-0.09-34.10%-0.07-27.20%-0.049120.55%-0.011657.89%-0.08-92.62%-0.0522-628.30%-0.0386-1,722.22%-0.0146-2,000.00%-0.19
Diluted earning per share -111.21%-0.0245-12.50%-0.09-34.10%-0.07-27.20%-0.049120.55%-0.011657.89%-0.08-92.62%-0.0522-628.30%-0.0386-1,722.22%-0.0146-2,000.00%-0.19
Other composite income
Total composite income -110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M-1,396.25%-41.89M
Total composite income of parent company owners -110.65%-5.38M-13.16%-20.03M-34.08%-15.39M-26.99%-10.78M20.45%-2.55M57.74%-17.7M-92.78%-11.48M-623.82%-8.49M-1,791.60%-3.21M-1,396.25%-41.89M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg